Posts

Showing posts with the label pharmaceutical solvents market size

Pharmaceutical Solvents Market is gaining rapid traction with Nouryon introducing new Kromasil, silica-based chromatography material, for pharmaceutical purification

Image
  Pharmaceutical Solvents are chemicals that are used in the synthesis of chemical substances. Most solvents can be found naturally in nature. However, in industries, solvents are introduced as they help in the speedy process of transformation. Solvents have a number of applications in several fields including pharmaceutical engineering, the food additives industry, cosmetic manufacturing, and industrial odor control. The typical demand for pharmaceutical solvents relies on drug discovery activities. Over the years, the pharmaceutical industry has witnessed significant growth in drug discovery R&D activates with robust growth of the industry itself. Recently, in March 2021, Pfizer Inc. initiated a Phase 1 study of novel oral antiviral therapy for COVID-19. As per the India Brand Equity Foundation (IBEF), the Indian pharmaceutical market was valued at US$ 20.03 billion in 2019, increasing US$ 18.12 in 2018. Hence, such R&D activities can augment growth of the pharmaceutical ...

Pharmaceutical Solvent Market Is Expected To Develop In Response To The World's Ageing Population

Image
  Pharmaceutical Solvents are chemicals that are utilized in the amalgamation of compound substances. Most solvents can be discovered normally in nature. Notwithstanding, in industries, solvents are presented as they help in the expedient cycle of change. Solvents have various applications in a few fields including pharmaceutical engineering, the food added substances industry, corrective manufacturing, and mechanical scent control. The run of the mill interest for pharmaceutical solvents depends on drug revelation exercises. Throughout the long term, the pharmaceutical industry has seen huge development in drug revelation R&D enacts with strong development of the actual industry. As of late, in March 2021, Pfizer Inc. started a Phase 1 investigation of novel oral antiviral treatment for COVID-19. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical market was esteemed at US$ 20.03 billion out of 2019, expanding US$ 18.12 in 2018. Thus, such R&D ...